$0.78
Today
as of Jul 22, 16:47 ET
Last 30 days
Recent Press Releases & News
Celularity Appoints Chief Operating Officer
Celularity and Fountain Life Announce Availability of Cenplacel-L for Investigational Use Under New Florida Law, Establishing Scalable Pathway for Advancement of Placental-Derived Cell Therapies
Celularity Releases CEO Letter to Shareholders
Overview
52-week range
$0.71
$4.35
2% of range
Avg surprise (last 0)
—
Avg reaction (last 1)
+0.6%
100% positive
Latest IV / EM
1962%
EM ±448.7% · $3 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Sep 30, 2025 | Sep 2025 | $-0.88 | — | — | — | — | financials |
| Fri Aug 29, 2025 | Jun/2025 | $-1.02 | — | — | — | — | earnings |
| Fri Aug 29, 2025 | Mar/2025 | $-0.84 | — | — | — | — | earnings |
| Fri May 9, 2025 | Dec/2024 | $-0.59 | — | — | — | +0.6% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.73 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.30 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-1.03 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-4.98 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-2.72 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-4.12 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5M | $6M | $11M | — | $9M | $12M | $15M | — |
| Cost of revenue | $4M | $5M | $4M | — | $4M | $2M | $2M | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-13M | $-16M | $-10M | — | $-12M | $-10M | $-7M | — |
| Net income | $-23M | $-25M | $-20M | — | $-16M | $-6M | $-22M | — |
| EPS (diluted) | $-0.88 | $-1.02 | $-0.84 | — | $-0.73 | $-0.30 | $-1.03 | — |
Balance sheet (quarterly)
| Metric | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $120,000 | $863,000 | $293,000 | $738,000 | $133,000 | $467,000 | $2M | $227,000 |
| Inventory | $3M | $4M | $6M | $5M | $4M | $3M | $4M | $6M |
| Total current assets | $11M | $17M | $22M | $21M | $15M | $18M | $23M | $20M |
| Total assets | $114M | $120M | $129M | $133M | $129M | $135M | $144M | $144M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $134M | $146M | $134M | $124M | $112M | $108M | $113M | $103M |
| Total equity | $-20M | $-25M | $-6M | $9M | $17M | $28M | $31M | $41M |